Evidence map›Paper›PMID 36033184›Full record

ArticleArthroscopy, sports medicine, and rehabilitation2022

Operative Time Less Than 1.5 Hours, Male Sex, Dependent Functional Status, Presence of Dyspnea, and Reoperations Within 30 days Are Independent Risk Factors for Readmission After ACLR.

Connor R Crutchfield, Jack R Zhong, Nathan J Lee, Thomas A Fortney, Christopher S Ahmad, T Sean Lynch

Abstract read
In one paragraph

Article in Arthroscopy, sports medicine, and rehabilitation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Connor R CrutchfieldColumbia University Irving Medical Center, New York, New York, U.S.A.; and Henry Ford Health Systems, Detroit, Michigan, U.S.A.
Jack R ZhongColumbia University Irving Medical Center, New York, New York, U.S.A.; and Henry Ford Health Systems, Detroit, Michigan, U.S.A.
Nathan J LeeColumbia University Irving Medical Center, New York, New York, U.S.A.; and Henry Ford Health Systems, Detroit, Michigan, U.S.A.
Thomas A FortneyColumbia University Irving Medical Center, New York, New York, U.S.A.; and Henry Ford Health Systems, Detroit, Michigan, U.S.A.
Christopher S AhmadColumbia University Irving Medical Center, New York, New York, U.S.A.; and Henry Ford Health Systems, Detroit, Michigan, U.S.A.
T Sean LynchColumbia University Irving Medical Center, New York, New York, U.S.A.; and Henry Ford Health Systems, Detroit, Michigan, U.S.A.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The purposes of this study are to use a large, patient-centered database to describe the 30-day readmission rate and to identify predictive risk factors for readmission after elective isolated ACLR. Methods: The National Surgical Quality Improvement Program Database was retrospectively queried for isolated ACLR procedures between 2011 and 2017. Current Procedural Terminology (CPT) codes were used to identify isolated ACLR patients. Those undergoing additional procedures such as meniscectomy or multi-ligamentous reconstruction were excluded. Readmissions were analyzed against demographic variables with bivariate analysis. Multivariate logistic regression was used to find independent risk factors for 30-day readmissions after ACLR. Results: A total of 11,060 patients (37.2% female) were included with an average age of 32.2 ± 10.6 years and mean body mass index (BMI) of 27.9 ± 6.5 kg/m Conclusions: Isolated ACLR is associated with low 30-day readmission rates. Operative time >1.5 hours, male sex, dependent functional status, the presence of dyspnea, and 30-day reoperations are independent risk factors for readmission that should be considered in patient selection and addressed with preoperative counseling. Level of Evidence: Level III, retrospective cohort study.

Identifiers

PMID36033184
PMCPMC9402418

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.